BC Cancer Foundation
Metastatic Breast Cancer Clinical Trial Forged by Epic Sciences, Canadian Consortium
Epic Sciences will donate its No Cell Left Behind platform to the clinical trial, which will enroll about 1,000 patients over three years.
British Columbia Pledges $2.1M in Funding for Personalized Cancer Therapy Program
The funding will support the British Columbia Cancer Agency's effort to use genome sequencing to develop personalized treatment strategies for cancer patients.
Data Published on First 100 Subjects in BC Cancer WGS Trial as Project Sets Sights on 5K Patients
Premium
Among 100 adults and six children recruited between June 2012 and August 2014, most were successfully sequenced and a majority of those had actionable results.
With New Funds, BC Cancer Agency Aims to Sequence 300 Patients for Personalized Onco-Genomics Trial
Premium
Researchers leading the POG trial are hoping this year to sequence the whole genomes of 300 cancer patients in an effort to find the best treatment options for them.
The goal is to analyze a variety of genomic techniques, including sequencing, to develop a test that will determine whether AML patients should receive chemotherapy or stem cell transplantation.